Press Releases

• Anixa Biosciences: Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology More
• Antheia: Appoints Eric d'Esparbes as Chief Financial Officer More
• Bio Usawa: Approval of BioUcenta by the Rwandan FDA More
• Cerus: Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting More
• Corcept: Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients With Platinum-Resistant Ovarian Cancer With Prior PARP Inhibitor Treatment More
• CytomX Therapeutics: Appoints Rachael Lester as Chief Business Officer More
• Genentech: Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer More
• Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss More More*
• Gilead: Trodelvy Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study More
• Gilead: Will Spotlight New Virology Data Across HIV, Viral Hepatitis and Respiratory Diseases at IDWeek 2025 More
• GondolaBio: Receives U.S. FDA Orphan Drug and Fast Track Designations for PORT-77 for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP) More
• HanchorBio: Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101 More
• IASO Bio: Approval of Clinical Trial Notification for Its BCMA CAR-T Product in Japan More
• Immusoft: Receives FDA Fast Track Designation for ISP-001, a First-in-Class Engineered B Cell Therapy for MPS I More
• Integrated DNA Technologies and Profluent: Collaborate to Unlock New Frontier of AI-driven Protein Design More
• Rune Labs: Appoints Digital Health Leader Adam Pellegrini to Board of Directors More
• Science Corp: PRIMA BCI Implant Restores Functional Central Vision to Patients With Geographic Atrophy Caused By Age-Related Macular Degeneration, a Leading Cause of Blindness, The New England Journal of Medicine Reports More
• Subtle Medical: Positive Findings From Proof-of-Concept Study With Bayer Investigating AI to Lower Gadolinium Dose in CE-MRI More
• Taiho Pharmaceutical: Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia More
• Vivace Therapeutics: VT3989, Best-in-Class, Hippo Pathway-Targeting Therapy, Demonstrates Promising Antitumor Activity in Refractory Mesothelioma More

Financial News

• Cala: Niterra Ventures Participates in Oversubscribed $50M Growth Financing Round for Cala More
• Exclusive VC Funding Data from BYTE51, with Special Big4Bio Pricing More
• Geron: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• How the Federal Government Shutdown Could Affect Three Bay Area Biotech IPOs More*
• How This Stanford Spinout, With a Fresh $14 Million, Plans to Revolutionize Health-Monitoring Biowearables More*
• NovaBay Pharmaceuticals: Regains Compliance With NYSE American Continued Listing Standards More
• QT Imaging: Plans to Relist on Nasdaq More
• Ventus Therapeutics: Enters Into a Collaboration and License Agreement With Genentech to Discover and Develop Small-Molecule Medicines Using Ventus' ReSOLVE Platform More 

Media/Misc Coverage

• CIRM: Explore How CIRM is Advancing California’s Scientific Vision More
• CRISPR Therapeutics Says Its New Gene Editing Tool is 'A Significant Advance' Over Prime Editing. Prime Medicine Disagrees More*
  
• ESMO: Exelixis ‘Franchise Molecule’ Reduces Death Risk by 20% in Stivarga Comparison Trial More
• Grail Reports Fewer False Alarms for Blood Cancer Test Ahead of FDA Filing More* More
• Rapt, Jeyou Are Itching to Start Phase 3 After Encouraging Mid-Stage Results in Urticaria More*
  
• Subscribe to LifeSci Startup for Updates on US Startups More
• Summit Plans to Take Lung Cancer Drug to FDA, Plots Combo Use and Study Changes More* More* More
• The Future of Everything: The Future of Topical Vaccines Podcast
• 23andMe: Nature and Nurture - A New Look at the Genetics of Reading Ability More
  

Companies

Career Center

• Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• CEO’s Perspective: Big Moves Come with Big Responsibility More
• CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: The Power of Peer Learning - Why Even Top Biotech Leaders Need Mentorship More
• Shape’s Former CSO Picks Up Tech Role at Moderna; Lilly Reels In Peter Marks More*
• What’s Next in Precision Medicine: Leadership Challenges and Opportunities More

• Biocom California CEO Summit (Bay Area/Wine Country) Oct 24
• 15th Annual PODD Conference Oct 27-28
• New Jersey Life Sciences & Biotech Conference Oct 28
• Biocom California CEO Summit (Los Angeles) Oct 29
• Pantheon 2025 Nov 6
• BIO-Europe 2025 Nov 11-12
• Copay, Reimbursement and Access Congress (Save 10% with VIP code: 25B4B10) Nov 18-20
• Pharma/Biotech Gross-To-Net Summit (Save 10% with VIP code: 25B4B10) Nov 18-20
• Patient Support Services Congress (Save 10% with VIP code: 25B4B10) Nov 20-21
• Compounding Pharmacy Compliance (Save 10% with VIP code: 25B4B10) Dec 9-10
• Trade and Channel Strategies (Save 10% with VIP code: 25B4B10) Dec 9-11
  
• Advancing Drug Development Forum Dec 11

SF Bay Sponsors